01 4CEPHALON
02 3EAGLE PHARMS
01 78791270
01 7Blank
01 7Y
01 72026-01-12
Patent Expiration Date : 2026-01-12
US Patent Number : 8791270
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22249
Patent Use Code : U-1542
Delist Requested :
Patent Use Description : FOR USE IN THE TREATME...
Patent Expiration Date : 2026-01-12
Patent Expiration Date : 2026-01-12
US Patent Number : 8791270
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22249
Patent Use Code : U-1542
Delist Requested :
Patent Use Description : FOR USE IN THE TREATME...
Patent Expiration Date : 2026-01-12
Patent Expiration Date : 2026-01-12
US Patent Number : 8791270
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22249
Patent Use Code : U-1542
Delist Requested :
Patent Use Description : FOR USE IN THE TREATME...
Patent Expiration Date : 2026-01-12
Patent Expiration Date : 2026-01-12
US Patent Number : 8791270
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22249
Patent Use Code : U-1542
Delist Requested :
Patent Use Description : FOR USE IN THE TREATME...
Patent Expiration Date : 2026-01-12
Patent Expiration Date : 2026-01-12
US Patent Number : 8791270
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208194
Patent Use Code : U-1790
Delist Requested :
Patent Use Description : FOR USE IN TREATMENT O...
Patent Expiration Date : 2026-01-12
Patent Expiration Date : 2026-01-12
US Patent Number : 8791270
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205580
Patent Use Code : U-1972
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-01-12
Patent Expiration Date : 2026-01-12
US Patent Number : 8791270
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205580
Patent Use Code : U-1971
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-01-12
